The oversubscribed private financing round, with primary participation from Fidelity Management & Research Company, The Column Group, ...

Results from the open-label extension portion of the Pacific trial saw bexicaserin able to elicit seizure reduction in ...

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.

SOUTH SAN FRANCISCO, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage, privately-held, biotherapeutics company developing regenerative cell therapies for disorders ...

- The oversubscribed private financing round, with primary participation from Fidelity Management & Research Company, The Column Group, Soleus Capital, Viking Global Investors, and Cormorant Asset ...

At the Annual Meeting of the American Epilepsy Society in December 2024, Neurona presented updated data from both the low-dose (n=5) and high-dose (n=5) cohorts of the company’s ongoing open ...

We spoke to Dr Meera Jindal, Consultant Fertility Specialist, Oasis Fertility, Hyderabad, who explained how to manage epilepsy during different phases of life. Link Between Hormones and Seizures ...

Kv7 is also a clinically validated target to regulate the hyperexcitable state in epilepsy. In vivo and in vitro studies have demonstrated that QRL-101 is more potent in threshold track studies and ...